Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.
NeoTX Therapeutics Ltd.
NeoTX Therapeutics Ltd.
7 Hills Pharma, LLC
Travera Inc
Incyte Corporation
Incyte Corporation
Telix Pharmaceuticals (Innovations) Pty Limited
Sotio Biotech Inc.
Travera Inc
Molecular Templates, Inc.
Xencor, Inc.
Incyte Corporation
AbbVie
AbbVie
Incyte Corporation
Incyte Corporation
Incyte Corporation
Shenzhen BinDeBio Ltd.
INSYS Therapeutics Inc